Intuitive Surgical, Inc. $ISRG Shares Sold by Ameriprise Financial Inc.

Ameriprise Financial Inc. reduced its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,654,927 shares of the medical equipment provider’s stock after selling 31,910 shares during the period. Ameriprise Financial Inc.’s holdings in Intuitive Surgical were worth $899,927,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of ISRG. Norges Bank acquired a new stake in Intuitive Surgical during the second quarter worth approximately $2,569,260,000. Vanguard Group Inc. boosted its holdings in shares of Intuitive Surgical by 2.1% during the second quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock worth $18,115,025,000 after purchasing an additional 670,302 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in shares of Intuitive Surgical by 20.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock valued at $1,680,922,000 after purchasing an additional 566,979 shares during the period. Jennison Associates LLC grew its position in shares of Intuitive Surgical by 20.4% in the second quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider’s stock valued at $1,696,738,000 after purchasing an additional 528,359 shares during the period. Finally, Wellington Management Group LLP increased its stake in Intuitive Surgical by 15.0% in the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock valued at $1,732,975,000 after purchasing an additional 457,080 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other Intuitive Surgical news, EVP Henry L. Charlton sold 13,731 shares of the company’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $7,963,980.00. Following the completion of the transaction, the executive vice president owned 3,056 shares in the company, valued at $1,772,480. This represents a 81.80% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Brian Edward Miller sold 3,500 shares of Intuitive Surgical stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the sale, the executive vice president owned 5,758 shares in the company, valued at $3,310,850. This represents a 37.81% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 109,043 shares of company stock worth $60,816,225 in the last ninety days. 0.70% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on ISRG. HSBC raised their price target on Intuitive Surgical from $595.00 to $644.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Daiwa Capital Markets upped their price target on shares of Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a research report on Friday, October 24th. Citigroup downgraded shares of Intuitive Surgical from a “buy” rating to a “neutral” rating and cut their price target for the stock from $650.00 to $635.00 in a research note on Thursday. Hsbc Global Res upgraded shares of Intuitive Surgical to a “strong-buy” rating in a report on Thursday, October 23rd. Finally, Sanford C. Bernstein restated an “outperform” rating and set a $685.00 price objective on shares of Intuitive Surgical in a report on Tuesday, October 21st. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $608.79.

Intuitive Surgical Trading Down 0.9%

Shares of ISRG stock opened at $542.32 on Friday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The company has a market cap of $194.41 billion, a PE ratio of 71.74, a P/E/G ratio of 5.03 and a beta of 1.68. The company’s fifty day simple moving average is $529.62 and its 200-day simple moving average is $506.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter in the previous year, the firm posted $1.84 earnings per share. The firm’s quarterly revenue was up 22.9% on a year-over-year basis. Equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.